Sydney, Oct 23, 2007 (ABN Newswire) - Compumedics Limited (ASX: CMP) - 2007 Annual Investor Update - Mr David Burton, Chairman; Compumedics Limited (ASX: CMP) present the following audio webcast regarding "2007 Annual Investor Update". You may also download this audio webcast to your computer or portable audio player.
Broadcaster: Compumedics Limited (ASX: CMP)
Broadcast Title: 2007 Annual Investor Update
Broadcast Type: Audio stream
Audio webcast Link:
Listen to the Audio stream and view the announcement for Compumedics Limited (ASX: CMP) below.
http://abnnewswire.net/vlnk/FL441L49
This Audio Cast is based on streaming audio sent in compressed form over the internet and displayed as it arrives. You do not have to wait for the whole file to be downloaded before you can hear it, instead the media is sent in a continuous stream and is played immediately as it reaches your computer. Please note that during live broadcasts there can be a delay of approximately 1-2 minutes, depending on traffic through your Internet Service Provider.
Minimum requirement for playing the multimedia links are; at least a 28.8k modem and sufficient memory and hard disk space to run Windows Media Player or Real Player. In addition, some media links contain material requiring the ability to run Flash Multimedia.
About COMPUMEDICS LIMITED
Compumedics Limited, founded in 1987, is a global leader in the design and manufacture of diagnostic technologies for sleep disorders, neurophysiology and cardiology. In 1987 Compumedics established Asia Pacific's first fully computerised sleep laboratory. Compumedics holds an 80% share of the Australian sleep-diagnostic market, and has a major and rapidly growing presence in the US, European and Asian markets for its sleep, neurological, and Doppler blood-flow diagnostic monitoring devices. Compumedics has grown to become a global medical diagnostic company with world leadership in three of the most exciting high-growth sectors and some 12,000 systems installed. Compumedics' businesses now include core and pioneering sleep-diagnostics (Sleep Division), neuro-diagnostics (Neuroscan and Neuroscience Divisions), and non-invasive blood-flow diagnostics (DWL Division). All of these fields were pioneered or discovered in the 1980s, validated in the 1990s and are only now undergoing rapid commercialisation into the rapidly expanding $1 billion plus global market.
News 
